Impax Asset Management Group plc
Interim Results Investor Presentation
Interim Results Investor Presentation via Webinar: open to all investors
Impax Asset Management Group plc is pleased to announce that its CEO, Ian Simm, and CFO, Charlie Ridge, will present its results for the six months to 31 March 2021.
The event will take place on Friday 28 May 2021 at 11.45am
The online presentation is open to existing and potential shareholders and registration is free. Questions can be submitted during the presentation and will be addressed at the end of it.
To register for the event, please go to: https://www.equitydevelopment.co.uk/news-and-events/impax-am-interim-results-investor-presentation-with-qa-28-may-2021
A recording will be available shortly after the event at https://www.equitydevelopment.co.uk
For more information please contact:
Equity Development Ltd. - Hannah Crowe
020 7065 2690
Notes to Editors - About Impax Asset Management
Impax Asset Management manages or advises on both listed and private markets strategies. The Company's investments are based on the strong conviction that population dynamics, resource scarcity, inadequate infrastructure and environmental constraints will profoundly shape global markets, creating investment risks and opportunities. Impax expects that these trends, reflecting the transition towards a more sustainable global economy, will drive earnings growth for well-positioned companies. Impax's proprietary investment framework identifies and calibrates the rising risks and expanding opportunities from this transition and guides the search for investments that will deliver long term outperformance.
For further information please visit www.impaxam.com.
Issued in the
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS